Substantiation of Rational Choice of Statin Therapy in Ukraine

Oksana Tryhubchak

Abstract: This study was conducted using marketing, pharmacoeconomical research of statins in Ukraine. It was found that the largest number of people taking statins use atorvastatin (51 %), simvastatin (31 %), rosuvastatin (16 %), lovastatin (2 %). costs minimization, cost-effectiveness and cost-utility analysis it was chose the least costly statins in Ukraine. We found differences in seven Issues of State Formulary of Drugs in Ukraine for the statin groups. The well-founded pharmacoeconomic benefits of rosuvastatin 10 mg included reducing the risk of morbidity and mortality, for atorvasatin 10 mg the reducing of low-density lipoprotein

Keywords: statin, rational choice, market analysis, pharmacoeconomics, pharmacoepidemiology

How to Cite?: Oksana Tryhubchak, "Substantiation of Rational Choice of Statin Therapy in Ukraine", Volume 7 Issue 1, January 2018, International Journal of Science and Research (IJSR), Pages: 1611-1622, https://www.ijsr.net/getabstract.php?paperid=ART20179723, DOI: https://dx.doi.org/10.21275/ART20179723